A detailed history of Parsec Financial Management, Inc. transactions in Geron Corp stock. As of the latest transaction made, Parsec Financial Management, Inc. holds 15,000 shares of GERN stock, worth $61,050. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,000
Previous 17,335 13.47%
Holding current value
$61,050
Previous $41,000 21.95%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 06, 2023

SELL
$2.14 - $3.4 $4,996 - $7,939
-2,335 Reduced 13.47%
15,000 $32,000
Q4 2022

Feb 06, 2023

BUY
$2.03 - $2.42 $35,190 - $41,950
17,335 New
17,335 $41,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.54B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Parsec Financial Management, Inc. Portfolio

Follow Parsec Financial Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parsec Financial Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Parsec Financial Management, Inc. with notifications on news.